Shopping Cart 0
Cart Subtotal
USD 0

Merck KGaA (MRK) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Merck KGaA (Merck), a subsidiary of E. Merck KG, is a pharmaceutical and chemical company. It discovers, develops and manufactures prescription drugs to treat cancer, multiple sclerosis, and infertility and over-the-counter products for colds and pain; and develops liquid crystal mixtures, OLED materials and cosmetic active ingredients. The company also provides a wide range of products including lab water systems to gene editing tools, cell lines, antibodies and end-to-end systems. Merck serves healthcare, performance materials and life sciences markets. It has presence in Europe, North America, Asia-Pacific, Latin America and Middle East and Africa. Merck is headquartered in Darmstadt, Hesse, Germany.

Merck KGaA (MRK)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 6

List of Figures 7

Merck KGaA, Medical Equipment, Deals By Year, 2012 to YTD 2018 8

Merck KGaA, Medical Equipment Deals By Type, 2012 to YTD 2018 9

Merck KGaA, Medical Equipment, Deals By Region, 2012 to YTD 2018 10

Merck KGaA, Medical Equipment, Deals By Market, 2012 to YTD 2018 11

Merck KGaA, Medical Equipment, Deals Summary, 2012 to YTD 2018 12

Merck KGaA, Medical Equipment, Deal Details 15

Asset Purchase 15

Sigma-Aldrich Acquires Duolink Product Portfolio from Olink Bioscience 15

BioReliance To Acquire Rights To Big Blue Colonies and Cell Lines From Agilent Technologies 16

Venture Financing 17

DNA Script Raises USD13.2 Million in Series A Financing 17

SerImmune Raises USD8 Million in Venture Financing 19

Partnerships 20

Sysmex Enters Into Licensing Agreement With Merck Millipore 20

MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test 21

Merck and ArcherDX Enter into Co-Development Agreement 22

Definiens Enters into Co-Development Agreement with Merck 23

Merck Enters into Co-Development Agreement with Alibaba Health 24

MilliporeSigma Enters into Distribution Agreement with HistoCyte Labs 25

Foundation Medicine Enters into Partnership with Merck 26

HTG Molecular Diagnostics Enters into Agreement with Merck 27

Exosome Diagnostics Enters into Agreement with Merck 28

Guardant Health Enters into Agreement with AstraZeneca, Merck and Pfizer 29

BioMed X Enters into Agreement with Merck 30

HTG Molecular Diagnostics Enters into Agreement with Merck 31

R-Biopharm Enters into Agreement with Merck 32

Emulate Expands Research Agreement with Merck 33

Merck and Pfizer Enters into Agreement with Dako 34

Sigma-Aldrich Enters into Distribution Agreement with LGC 35

Sigma-Aldrich and GenapSys to Co-Market Genius system 36

Merck Serono Enters into Co- Development Agreement with Illumina 37

Abcam Enters into Co-Marketing Agreement with Cell Marque for IVD IHC RabMAb Antibodies 38

Ventana Medical Systems Enters into Co-Development Agreement with Merck Serono for Companion Diagnostic Test 39

True Diagnostics Enters into Co-Marketing Agreement With Merck 40

Sigma-Aldrich Enters Into Distribution Agreement With Biomatrica For Biospecimen Storage Products 41

Firefly BioWorks Enters Into Distribution Agreement With EMD Millipore 42

Life Technologies Enters Into Agreement With Merck Serono To Develop And Commercialize Companion Diagnostics 43

Gyros And EMD Millipore Enter Into Agreement To Develop And Commercialize Immunoassay Kits 44

Luminex Extends Distribution Agreement With EMD Millipore 45

Alchemia Enters Into Collaboration Agreement with Merck Serono 46

GE Healthcare Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich 47

Sigma Life Science Enters Into Distribution Agreement With Olink Bioscience For Duolink Technology 48

EMD Millipore Enters Into Co-Development Agreement With Sistemic For Stem Cell Markers 49

Merck Serono Enters Into Co-Development Agreement With Auxogyn For Early Embryo Viability Assessment Test 50

Sage Labs Enters Into Agreement With Ekam Imaging To Develop Imaging Assays 51

SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For PhenoFluor 52

Little Things Factory Enters Into Distribution Agreement With Sigma-Aldrich For Microreactors 53

Mendor Enters Into Distribution Agreement With Merck Serono 54

EMD Millipore Enters into Licensing Agreement with Singulex 55

Merck Extends Licensing Agreement with Progyny 56

Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents 57

Cyprotex Enters Into Licensing Agreement With Sigma For Zinc Finger Nuclease Technology 58

Equity Offering 59

KalVista Pharma Raises USD9.1 Million in Private Placement of Shares 59

Debt Offering 60

Merck Raises USD916 Million in Private Placement of 0.75% Bonds Due 2019 60

Merck Raises USD801.4 Million in Private Placement of 0.23% Bonds Due 2017 61

Merck Raises USD629.7 Million in Private Placement of 1.375% Bonds Due 2022 62

Asset Transactions 63

Zydus Healthcare Acquires Six Brands from Merck 63

Honeywell International Acquires Research Chemicals Business from Sigma-Aldrich 64

Acquisition 66

Merck to Acquire Natrix Separations 66

Merck Acquires Sigma-Aldrich for USD17 Billion 67

Sigma-Aldrich Acquires Cell Marque 69

Proxy Labs Acquires MicroSafe Laboratories From Millipore 70

Merck KGaA-Key Competitors 71

Merck KGaA-Key Employees 72

Merck KGaA-Locations And Subsidiaries 73

Head Office 73

Other Locations & Subsidiaries 73

Recent Developments 83

Strategy And Business Planning 83

Sep 28, 2017: Merck On Course To Achieve Objectives for 2018 83

Sep 05, 2017: Merck Prepares Strategic Options for the Consumer Health Business 85

Jul 21, 2017: Merck Opens New Application Laboratory in Shanghai 86

Jun 29, 2017: Merck Expands Packaging Capacity at Swiss Biotech Manufacturing Site of Aubonne 87

Jun 20, 2017: Merck Ventures Creates New Immuno-Oncology Company iOnctura 88

May 16, 2017: Merck: Optimizing the Further Development of the Darmstadt Site 89

Apr 20, 2017: Merck Provides Upgraded Manufacturing Capabilities to BioInvent with Single-use Mobius Bioreactors 90

Jan 17, 2017: Merck Opens Production Facility Exclusively for Meglumine in Spain 91

Financial Announcements 92

Feb 02, 2018: Merck Announces Fourth-Quarter and Full-Year 2017 Financial Results 92

Nov 09, 2017: Merck Confirms Outlook for 2017 Despite a Challenging Third Quarter 97

Aug 03, 2017: Q2 2017: Merck Sets Course for Future Growth 99

May 18, 2017: Merck Continues to Grow Profitably in the First Quarter 101

Corporate Communications 103

Jan 26, 2018: Merck Appoints Dirk Toepfer as Chief Information Officer 103

Dec 15, 2017: Petra Wicklandt Appointed Head of Corporate Affairs at Merck 104

Dec 12, 2017: Allan Gabor Takes Over the Leadership of Merck in China 105

Dec 06, 2017: Merck: Resignation of Managing Director 106

Sep 11, 2017: Merck Names Heidi Fagerholm as New Head of Advanced Technologies 107

Aug 03, 2017: Executive Board Changes at Merck 108

Jul 21, 2017: Merck Opens New Application Laboratory in Shanghai 109

May 12, 2017: Constantin Birnstiel to Become Head of Group Communications at Merck 110

Feb 08, 2017: North American Businesses of Merck Certified as 2017 Top Employer 111

Product News 112

Apr 04, 2018: MilliporeSigma to Launch New Flow Cytometer, Host CellStream Workshop at CYTO 2018 112

Other Significant Developments 113

Jul 26, 2018: Merck and Innocore pharmaceuticals to improve patient compliance with new drug delivery technology 113

Jun 19, 2018: Merck to distribute HistoCyte Laboratories' cell line products 114

Apr 05, 2018: Merck and Schneider Electric Sign MoU to Advance China's Biopharmaceutical Industry 115

Feb 21, 2018: Merck Invests Additional EUR40 Million to Enhance Manufacturing and Distribution in Asia 116

Jul 12, 2017: Merck Refines Western European Life Science Production Site Network 117

May 18, 2017: Rational Surgical Solutions integrates Merck Manual of Medicine into Surgery CareSite 118

Mar 21, 2017: Merck Accelerator Hits New Peak of Applications 119

Mar 09, 2017: Merck Generates Record Sales and Continues to Grow Profitably in 2016 120

Jan 12, 2017: Merck and Palantir Launch New Healthcare Acceleration Partnership 122

Appendix 123

Methodology 123

About GlobalData 123

Contact Us 123

Disclaimer 123


List Of Figure

List of Figures

Merck KGaA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Merck KGaA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Merck KGaA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Merck KGaA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Merck KGaA, Medical Equipment, Deals By Year, 2012 to YTD 2018 8

Merck KGaA, Medical Equipment, Deals by Type, 2012 to YTD 2018 9

Merck KGaA, Medical Equipment, Deals By Region, 2012 to YTD 2018 10

Merck KGaA, Medical Equipment, Deals by Market, 2012 to YTD 2018 11


List Of Table

List of Tables

Merck KGaA, Medical Equipment, Key Facts, 2017 2

Merck KGaA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Merck KGaA, Medical Equipment, Deals By Year, 2012 to YTD 2018 8

Merck KGaA, Medical Equipment Deals By Type, 2012 to YTD 2018 9

Merck KGaA, Medical Equipment, Deals By Region, 2012 to YTD 2018 10

Merck KGaA, Deals By Market, 2012 to YTD 2018 11

Merck KGaA, Medical Equipment, Deals Summary, 2012 to YTD 2018 12

Sigma-Aldrich Acquires Duolink Product Portfolio from Olink Bioscience 15

BioReliance To Acquire Rights To Big Blue Colonies and Cell Lines From Agilent Technologies 16

DNA Script Raises USD13.2 Million in Series A Financing 17

SerImmune Raises USD8 Million in Venture Financing 19

Sysmex Enters Into Licensing Agreement With Merck Millipore 20

MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test 21

Merck and ArcherDX Enter into Co-Development Agreement 22

Definiens Enters into Co-Development Agreement with Merck 23

Merck Enters into Co-Development Agreement with Alibaba Health 24

MilliporeSigma Enters into Distribution Agreement with HistoCyte Labs 25

Foundation Medicine Enters into Partnership with Merck 26

HTG Molecular Diagnostics Enters into Agreement with Merck 27

Exosome Diagnostics Enters into Agreement with Merck 28

Guardant Health Enters into Agreement with AstraZeneca, Merck and Pfizer 29

BioMed X Enters into Agreement with Merck 30

HTG Molecular Diagnostics Enters into Agreement with Merck 31

R-Biopharm Enters into Agreement with Merck 32

Emulate Expands Research Agreement with Merck 33

Merck and Pfizer Enters into Agreement with Dako 34

Sigma-Aldrich Enters into Distribution Agreement with LGC 35

Sigma-Aldrich and GenapSys to Co-Market Genius system 36

Merck Serono Enters into Co- Development Agreement with Illumina 37

Abcam Enters into Co-Marketing Agreement with Cell Marque for IVD IHC RabMAb Antibodies 38

Ventana Medical Systems Enters into Co-Development Agreement with Merck Serono for Companion Diagnostic Test 39

True Diagnostics Enters into Co-Marketing Agreement With Merck 40

Sigma-Aldrich Enters Into Distribution Agreement With Biomatrica For Biospecimen Storage Products 41

Firefly BioWorks Enters Into Distribution Agreement With EMD Millipore 42

Life Technologies Enters Into Agreement With Merck Serono To Develop And Commercialize Companion Diagnostics 43

Gyros And EMD Millipore Enter Into Agreement To Develop And Commercialize Immunoassay Kits 44

Luminex Extends Distribution Agreement With EMD Millipore 45

Alchemia Enters Into Collaboration Agreement with Merck Serono 46

GE Healthcare Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich 47

Sigma Life Science Enters Into Distribution Agreement With Olink Bioscience For Duolink Technology 48

EMD Millipore Enters Into Co-Development Agreement With Sistemic For Stem Cell Markers 49

Merck Serono Enters Into Co-Development Agreement With Auxogyn For Early Embryo Viability Assessment Test 50

Sage Labs Enters Into Agreement With Ekam Imaging To Develop Imaging Assays 51

SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For PhenoFluor 52

Little Things Factory Enters Into Distribution Agreement With Sigma-Aldrich For Microreactors 53

Mendor Enters Into Distribution Agreement With Merck Serono 54

EMD Millipore Enters into Licensing Agreement with Singulex 55

Merck Extends Licensing Agreement with Progyny 56

Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents 57

Cyprotex Enters Into Licensing Agreement With Sigma For Zinc Finger Nuclease Technology 58

KalVista Pharma Raises USD9.1 Million in Private Placement of Shares 59

Merck Raises USD916 Million in Private Placement of 0.75% Bonds Due 2019 60

Merck Raises USD801.4 Million in Private Placement of 0.23% Bonds Due 2017 61

Merck Raises USD629.7 Million in Private Placement of 1.375% Bonds Due 2022 62

Zydus Healthcare Acquires Six Brands from Merck 63

Honeywell International Acquires Research Chemicals Business from Sigma-Aldrich 64

Merck to Acquire Natrix Separations 66

Merck Acquires Sigma-Aldrich for USD17 Billion 67

Sigma-Aldrich Acquires Cell Marque 69

Proxy Labs Acquires MicroSafe Laboratories From Millipore 70

Merck KGaA, Key Competitors 71

Merck KGaA, Key Employees 72

Merck KGaA, Subsidiaries 73

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Merck KGaA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.